MFG-E8 Knockout Aggravated Nonalcoholic Steatohepatitis by Promoting the Activation of TLR4/NF-κB Signaling in Mice
Nonalcoholic steatohepatitis (NASH) is the common liver disease characterized by hepatic steatosis, inflammation, and fibrosis; there are no approved drugs to treat this disease because of incomplete understanding of pathophysiological mechanisms of NASH. Milk fat globule-epidermal growth factor-fac...
Saved in:
Main Authors: | Jun Hu (Author), Hui Du (Author), Yinglin Yuan (Author), Peipei Guo (Author), Junxia Yang (Author), Xinru Yin (Author), Jin Liu (Author), Shengwang Wu (Author), Jingyuan Wan (Author), Xia Gong (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Host ALDH2 deficiency aggravates nonalcoholic steatohepatitis through gut-liver axis
by: Zhan-Ming Li, et al.
Published: (2023) -
Wedelolactone Mitigates Alcoholic Steatohepatitis via Modulating the TLR4/MyD88/NF-κB Pathway
by: Tao Jiang, et al.
Published: (2024) -
Oligonucleotide therapies for nonalcoholic steatohepatitis
by: Sixu Li, et al.
Published: (2024) -
Semaglutide in the treatment of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
by: Magdalena Mazurek, et al.
Published: (2023) -
Expression of TLR9 and NF-κB in condyloma acuminatum
by: Guangwen YIN, et al.
Published: (2021)